4//SEC Filing
New Leaf Venture Management III, L.L.C. 4
Accession 0001104659-18-042317
CIK 0001674365other
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 4:57 PM ET
Size
33.9 KB
Accession
0001104659-18-042317
Insider Transaction Report
Form 4
Aptinyx Inc.APTX
Transactions
- Conversion
Series A-1 Convertible Preferred Stock
2018-06-25−28,895,188→ 0 total(indirect: See footnote)→ Common Stock (1,047,450 underlying) - Conversion
Series B Convertible Preferred Stock
2018-06-25−6,712,986→ 0 total(indirect: See footnote)→ Common Stock (243,345 underlying) - Conversion
Common Stock
2018-06-25+1,047,450→ 1,047,450 total(indirect: See footnote) - Conversion
Common Stock
2018-06-25+1,197,076→ 2,244,526 total(indirect: See footnote) - Conversion
Common Stock
2018-06-25+243,345→ 243,345 total(indirect: See footnote) - Purchase
Common Stock
2018-06-25$16.00/sh+125,000$2,000,000→ 368,345 total(indirect: See footnote) - Conversion
Common Stock
2018-06-25+552,208→ 2,796,734 total(indirect: See footnote) - Purchase
Common Stock
2018-06-25$16.00/sh+125,000$2,000,000→ 2,921,734 total(indirect: See footnote) - Conversion
Series A-2 Convertible Preferred Stock
2018-06-25−33,022,786→ 0 total(indirect: See footnote)→ Common Stock (1,197,076 underlying) - Conversion
Series B Convertible Preferred Stock
2018-06-25−15,233,315→ 0 total(indirect: See footnote)→ Common Stock (552,208 underlying)
New Leaf Ventures III, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2018-06-25+243,345→ 243,345 total(indirect: See footnote) - Conversion
Series A-1 Convertible Preferred Stock
2018-06-25−28,895,188→ 0 total(indirect: See footnote)→ Common Stock (1,047,450 underlying) - Conversion
Common Stock
2018-06-25+1,197,076→ 2,244,526 total(indirect: See footnote) - Conversion
Common Stock
2018-06-25+552,208→ 2,796,734 total(indirect: See footnote) - Conversion
Series B Convertible Preferred Stock
2018-06-25−6,712,986→ 0 total(indirect: See footnote)→ Common Stock (243,345 underlying) - Conversion
Common Stock
2018-06-25+1,047,450→ 1,047,450 total(indirect: See footnote) - Purchase
Common Stock
2018-06-25$16.00/sh+125,000$2,000,000→ 2,921,734 total(indirect: See footnote) - Purchase
Common Stock
2018-06-25$16.00/sh+125,000$2,000,000→ 368,345 total(indirect: See footnote) - Conversion
Series A-2 Convertible Preferred Stock
2018-06-25−33,022,786→ 0 total(indirect: See footnote)→ Common Stock (1,197,076 underlying) - Conversion
Series B Convertible Preferred Stock
2018-06-25−15,233,315→ 0 total(indirect: See footnote)→ Common Stock (552,208 underlying)
Transactions
- Conversion
Common Stock
2018-06-25+1,197,076→ 2,244,526 total(indirect: See footnote) - Purchase
Common Stock
2018-06-25$16.00/sh+125,000$2,000,000→ 2,921,734 total(indirect: See footnote) - Conversion
Series A-1 Convertible Preferred Stock
2018-06-25−28,895,188→ 0 total(indirect: See footnote)→ Common Stock (1,047,450 underlying) - Conversion
Series A-2 Convertible Preferred Stock
2018-06-25−33,022,786→ 0 total(indirect: See footnote)→ Common Stock (1,197,076 underlying) - Conversion
Series B Convertible Preferred Stock
2018-06-25−15,233,315→ 0 total(indirect: See footnote)→ Common Stock (552,208 underlying) - Conversion
Series B Convertible Preferred Stock
2018-06-25−6,712,986→ 0 total(indirect: See footnote)→ Common Stock (243,345 underlying) - Purchase
Common Stock
2018-06-25$16.00/sh+125,000$2,000,000→ 368,345 total(indirect: See footnote) - Conversion
Common Stock
2018-06-25+1,047,450→ 1,047,450 total(indirect: See footnote) - Conversion
Common Stock
2018-06-25+552,208→ 2,796,734 total(indirect: See footnote) - Conversion
Common Stock
2018-06-25+243,345→ 243,345 total(indirect: See footnote)
Transactions
- Conversion
Series A-2 Convertible Preferred Stock
2018-06-25−33,022,786→ 0 total(indirect: See footnote)→ Common Stock (1,197,076 underlying) - Conversion
Common Stock
2018-06-25+552,208→ 2,796,734 total(indirect: See footnote) - Conversion
Common Stock
2018-06-25+243,345→ 243,345 total(indirect: See footnote) - Purchase
Common Stock
2018-06-25$16.00/sh+125,000$2,000,000→ 2,921,734 total(indirect: See footnote) - Purchase
Common Stock
2018-06-25$16.00/sh+125,000$2,000,000→ 368,345 total(indirect: See footnote) - Conversion
Series A-1 Convertible Preferred Stock
2018-06-25−28,895,188→ 0 total(indirect: See footnote)→ Common Stock (1,047,450 underlying) - Conversion
Common Stock
2018-06-25+1,047,450→ 1,047,450 total(indirect: See footnote) - Conversion
Common Stock
2018-06-25+1,197,076→ 2,244,526 total(indirect: See footnote) - Conversion
Series B Convertible Preferred Stock
2018-06-25−15,233,315→ 0 total(indirect: See footnote)→ Common Stock (552,208 underlying) - Conversion
Series B Convertible Preferred Stock
2018-06-25−6,712,986→ 0 total(indirect: See footnote)→ Common Stock (243,345 underlying)
New Leaf BPO Associates I, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2018-06-25+1,047,450→ 1,047,450 total(indirect: See footnote) - Conversion
Series B Convertible Preferred Stock
2018-06-25−6,712,986→ 0 total(indirect: See footnote)→ Common Stock (243,345 underlying) - Conversion
Series A-1 Convertible Preferred Stock
2018-06-25−28,895,188→ 0 total(indirect: See footnote)→ Common Stock (1,047,450 underlying) - Conversion
Series A-2 Convertible Preferred Stock
2018-06-25−33,022,786→ 0 total(indirect: See footnote)→ Common Stock (1,197,076 underlying) - Purchase
Common Stock
2018-06-25$16.00/sh+125,000$2,000,000→ 2,921,734 total(indirect: See footnote) - Conversion
Common Stock
2018-06-25+552,208→ 2,796,734 total(indirect: See footnote) - Conversion
Common Stock
2018-06-25+243,345→ 243,345 total(indirect: See footnote) - Purchase
Common Stock
2018-06-25$16.00/sh+125,000$2,000,000→ 368,345 total(indirect: See footnote) - Conversion
Common Stock
2018-06-25+1,197,076→ 2,244,526 total(indirect: See footnote) - Conversion
Series B Convertible Preferred Stock
2018-06-25−15,233,315→ 0 total(indirect: See footnote)→ Common Stock (552,208 underlying)
Footnotes (6)
- [F1]Each share of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 27.58621-for-one basis immediately prior to the closing of the Issuer's initial public offering without payment or additional consideration. The shares of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock had no expiration date.
- [F2]These shares are held directly by New Leaf Ventures III, L.P. ("NLV-III"). The general partner of NLV-III is New Leaf Venture Associates III, L.P. ("NLVA-III"). The general partner of NLVA-III is New Leaf Venture Management III, L.L.C. ("Management-III"). Each of NLVA-III and Management-III may be deemed to have sole voting and investment power with respect to these securities. Each of NLVA-III and Management-III disclaim beneficial ownership of these securities and this report shall not be deemed an admission that NLVA-III or Management-III are beneficial owners of such securities for purposes of Section 16 or any other purpose, except to the extent of their respective pecuniary interests therein. Liam T. Ratcliffe, a member of the Issuer's board of directors, Ronald M. Hunt and Vijay K. Lathi are the managers of Management-III (each, a "Manager" and collectively, the "Managers") and may each be deemed to have shared voting and investment power with respect to these securities.
- [F3]Each of the Managers disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
- [F4]These shares are held directly by New Leaf Ventures Biopharma Opportunities I, L.P. ("NLV Biopharma"). The general partner of NLV Biopharma is New Leaf BPO Associates I, L.P. ("NLBA-I"). The general partner of NLBA-I is Management-III. Each of NLBA-I and Management-III may be deemed to have sole voting and investment power with respect to these securities. Each of NLBA-I and Management-III disclaim beneficial ownership of these securities and this report shall not be deemed an admission that NLBA-I or Management-III are beneficial owners of such securities for purposes of Section 16 or any other purpose, except to the extent of their respective pecuniary interests therein.
- [F5]Each of the Managers may be deemed to have shared voting and investment power with respect to these securities. Each of the Managers disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
- [F6]On June 25, 2018, each of NLV-III and NLV Biopharma purchased 125,000 and 125,000 shares of common stock of the Issuer at a price of $16.00 per share, respectively, pursuant to an underwritten public offering.
Documents
Issuer
Aptinyx Inc.
CIK 0001674365
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001625657
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 4:57 PM ET
- Size
- 33.9 KB